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ABSTRACT: Advances in nanotechnology have provided
new opportunities for the design of next-generation nucleic
acid biosensors and diagnostics. Indeed, combining advances
in functional nanoparticles, DNA nanotechnology, and
nuclease-enzyme-based ampliﬁcation can give rise to new
assays with advantageous properties. In this work, we
developed a microRNA (miRNA) assay using bright
ﬂuorescent quantum dots (QDs), simple DNA probes, and
the enzyme duplex-speciﬁc nuclease. We employed an
isothermal target-recycling mechanism, where a single miRNA target triggers the cleavage of many DNA signal probes. The
incorporation of DNA-functionalized QDs enabled a quantitative ﬂuorescent readout, mediated by Förster resonance energy
transfer (FRET)-based interaction with the DNA signal probes. Our approach splits the reaction in two, performing the
enzyme-mediated ampliﬁcation and QD-based detection steps separately such that each reaction could be optimized for
performance of the active components. Target recycling gave ca. 3 orders of magnitude ampliﬁcation, yielding highly sensitive
detection with a limit of 42 fM (or 1.2 amol) of miR-148, with excellent selectivity versus mismatched sequences and other
miRNAs. Furthermore, we used an alternative target (miR-21) and FRET pair for direct and absolute quantiﬁcation of miR-21
in RNA extracts from human cancer and normal cell lines.
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■ INTRODUCTION
The monitoring of microRNA (miRNA) expression can be
used to predict the development and prognosis of many
pathological conditions;1,2 therefore, miRNA detection is
expected to become an important aspect of clinical
diagnostics.1,3,4 However, it is particularly challenging for
absolute and direct quantiﬁcation of miRNAs due to their
short lengths, low abundances, degradation susceptibility, and
high sequence homology. Therefore, the development of novel
detection approaches is of a priority.
Through the advancement of nanotechnology,5,6 a variety of
nanomaterial-based detection platforms have been developed,
which endeavor to meet the demanding requirements of
clinical practice,7 such as reliability, accuracy, eﬃciency, ease of
use, versatility, and cost-eﬀectiveness. Among the most
promising nanomaterials used in such platforms are colloidal
semiconductor nanocrystals or quantum dots (QDs),8,9 which
have demonstrated great potential in medical diagnosis10 and
biological studies.11 QDs exhibit numerous unique character-
istics including narrow-emission and broad-absorption spectra,
high quantum yield (QY), size- or composition-tunable
photoluminescence (PL), resistance to photodegradation,
and a range of surface chemical modiﬁcations allowing display
of various functional groups. In particular, the combination of
such properties makes QDs excellent components in Förster
resonance energy transfer (FRET)12 systems, when assembled
and functionalized with various bioderived components
(proteins,13−15 peptides,16,17 nucleic acids, etc.) for a variety
of applications.
A particular avenue of interest in current research is hybrid
systems composed of QDs and DNA, enabling the detection of
various nucleic acid biomarkers.18−37 Comparing with some
other ﬂuorescence measurements, the use of QDs in nucleic
acid detection has exhibited signiﬁcant merits, including high
signal-to-noise ratios, low sample consumption, and improved
sensitivity.18 Indeed, the advantages of QDs for ﬂuorescence or
FRET have previously been applied to the detection of
microRNAs (miRNAs).38 However, if detection relies solely
on hybridization events without ampliﬁcation, limits of
detection (LOD) are typically restricted within the pM-to-
nM range.31,32,36,37 To improve on this, various isothermal
ampliﬁcation methods have been used in combination with
QD-based nanosensors, such as exponential ampliﬁcation
reaction,25 target-recycled enzyme-free ampliﬁcation,39 enzy-
matic ampliﬁcation,26,28−30 and catalytic hairpin assembly
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ampliﬁcation.40 Such eﬀorts involving target or signal
ampliﬁcation have enabled fM-to-aM LOD to be achieved.
Despite their great promise, QDs suﬀer from several issues
that sometimes restrict performance in biosensing systems.
The biggest challenge is maintaining colloidal and ﬂuorescence
stability in aqueous biological environments.12 To this end,
QD surfaces must be carefully modiﬁed with hydrophilic
ligands to confer solubility and dispersity in complex biological
solutions. A particular complication of relevance to the present
work is that the conditions required for enzyme-mediated
ampliﬁcation are typically not favorable for QD stability and
performance. Many enzyme solutions and incubation buﬀers
have thiolated species (e.g., dithiothreitol (DTT)) added to
stabilize the enzyme; however, these species are particularly
harmful to QDs due to the inherent attraction to QD
surfaces,41 with subsequent displacement of attached species
ultimately leading to colloidal instability.42,43 Enzyme storage
and reaction buﬀers will typically come with a variety of ions
present, for example Na+, K+, and Mg2+, which can destabilize
the QDs by charge screening and interference with exciton
recombination.44,45 Temperature stability is a particular
problem when using QDs in sensing systems where enzyme-
mediated ampliﬁcation is performed, as temperatures exceed-
ing 50 °C are commonly employed. As a result, there is a need
to design sensing strategies that can utilize both QDs and
enzymes to take maximum advantage of these high-perform-
ance components.
FRET is highly distance dependent (1/r6, where r is the
separation distance between donor and acceptor). This
dependence tends to complicate the facile application of
QDs, as it necessitates that the surface coating must be of
minimal thickness, introducing an inherent compromise
between QD protection and FRET functionality.12 Commer-
cial streptavidin-coated QDs (SA-QD)25,28 have often been
used in QD−DNA biosensing systems. These enable
quantitative attachment of DNA probes without depleting
QD brightness.18 However, there is low FRET eﬃciency due
to the relatively large size of streptavidin (ca. 5 nm), which
greatly increases the overall distance between the QD and its
FRET partners on DNA probes. This lowers FRET eﬃciency
and the ultimate sensing limit. Unfortunately, direct attach-
ment of DNA to QDs does not typically yield very stable
particles (in contrast to gold nanoparticles), so this is not
commonly a viable option. There has been great progress in
the design of compact surface ligands that stabilize QDs and
facilitate bioconjugation. However, there is still progress to be
made for QDs to become versatile enough for use in the most
challenging sensing conditions, such as when coemployed with
enzymes.
In this work, we assess the utility of coemploying enzyme-
mediated target recycling for miRNA detection and ﬂuorescent
QDs as a sensitive signal transduction agent. Considering the
points discussed above, we set out to develop a miRNA
detection mechanism following some speciﬁc design criteria:
(1) to separate the enzyme incubation step from the QD
incubation and readout, so that the two reactions could be
optimized individually to maximize performance; (2) to have a
homogenous one-pot assay that did not require any ﬁltration
or cleaning steps; (3) to have a universal detection mechanism
that is not sequence-speciﬁc and that can potentially run in
parallel in a single solution (toward multiplexing); and (4) to
maximize FRET sensitivity by minimizing the donor−acceptor
separation distance.
We have developed an isothermal target-recycling-based
miRNA detection mechanism using a single enzyme (duplex-
speciﬁc-nuclease (DSN)),46 with a QD-based readout. Various
isothermal ampliﬁcation methods have been developed for
miRNAs analysis, such as loop-mediated isothermal ampliﬁca-
tion (LAMP), rolling circle ampliﬁcation (RCA), and hybrid-
ization chain reaction (HCR). LAMP has shown outstanding
speciﬁcity in a one-step reaction with a group of target-speciﬁc
primers; however, this technology has several intrinsic
disadvantages such as complex primer design and nonspeciﬁc
ampliﬁcation; RCA is an enzymatic process that can generate
superlong single-stranded DNA (ssDNA) molecules, but it is
very time-consuming because an additional ligation procedure
is always required before ampliﬁcation. Moreover, polymerases
are easily inhibited by the accumulated pyrophosphate
byproduct. The enzyme-free HCR method is able to provide
isothermal molecular signal ampliﬁcation in varied settings,
however, precise design of the hairpins is needed, but
systematic guidelines for designing hairpin sequences are
lacking. Besides, some nonspeciﬁc ampliﬁcation without target
miRNA is typically observed. DSN-based target recycling,
which has emerged as a versatile component in developing
bioanalytical strategies, has serially been applied for quantita-
tive detection of miRNAs owing to its sensitivity, speciﬁcity,
short assay time, and lower contamination risk. DSN shows a
strong preference for digesting DNA strands in double-
stranded DNA or in DNA−RNA hybrid duplexes but does
not show sequence speciﬁcity or cleave single-stranded DNA
or RNA. Additionally, it discriminates between fully matched
and slightly mismatched short duplexes.
Our approach splits the reaction in two, performing the
DSN-mediated ampliﬁcation and QD-based detection steps
separately such that each reaction can be optimized for
performance of the active components. The assay is one-pot
and homogenous, with no washing or ﬁltration. The enzyme is
not sequence-speciﬁc, and the single cascades are driven by
speciﬁc base-pairing of complementary sequences; therefore,
the mechanism should be universal and multiplexable. Finally,
FRET is maximized by employing QDs with a compact surface
layer and by using FRET probes that bind to the QDs in a
proximal orientation, minimizing donor−acceptor separation,
which is diﬃcult to obtain using typical “sandwich”
approaches. To show the method versatility, we developed
conﬁgurations for detecting miR-148 (a circulating miRNA
signiﬁcantly dysregulated during H1N1 infection47) and miR-
21 (which is upregulated in several pathological conditions
such as cancer and cardiovascular diseases and plays a crucial
role in the process of cell proliferation, cell invasiveness, and
angiogenesis48). By systematically exploring the DSN-based
cleavage reaction and QD-FRET-based signal readout, we have
achieved a detection limit of 42 fM (or 1.2 amol) of miR-148
in buﬀer, with excellent selectivity versus mismatched
sequences and other miRNAs. Finally, we employed a separate
system with a diﬀerent FRET pair to detect miR-21 in small
RNA extracts from human cancer and normal cell lines.
Overall, this work presents a sensitive miRNA detection
strategy, capable of functioning eﬀectively during coemploy-
ment of enzymes and QDs.
■ MATERIALS AND METHODS
Materials, reagents, detailed experimental process, and instrumenta-
tion used in the current work are listed in the Supporting Information.
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Assembly of His6-Tag DNA onto QDs. Oleic acid-capped
CdSxSe1−x/ZnS (core/shell) QDs (525 or 570 nm emission) in
organic solvent were made water-soluble through a ligand-exchange
reaction with a dihydrolipoic acid-based zwitterionic ligand as
previously described by Medintz et al.49 Chemoselective, aniline-
catalyzed hydrazone coupling chemistry50 was then used to conjugate
a hexahistidine (His6) peptide to amine-functionalized DNA
(HisDNA), which allowed them to ratiometrically self-assemble
onto the hydrophilic QDs. For QD−HisDNA preparation, QDs were
mixed with the indicated molar ratios of HisDNA in borate buﬀer (50
mM, pH 8.3) and incubated for 30−60 min prior to use. Successful
self-assembly was conﬁrmed by gel electrophoresis and analysis of
FRET interactions.
DSN Activity on DNA−miRNA Duplexes. The reaction
conditions (temperature and concentrations of MgCl2, DTT, and
the DSN enzyme) for the DSN cleavage step were ﬁrst optimized.
Here, a dual-labeled DNA probe with a black hole quencher 3
(BHQ3) at one end and the dye Alexa Fluor 594 (AF594) at the other
was used. In a typical DSN cleavage assay, the reaction was carried out
in a ﬁnal volume of 30 μL containing 40 nM DNA probe, various
target miRNA concentrations, and 0.01 U μL−1 DSN in the optimal
buﬀer (50 mM Tris−HCl, 15 mM MgCl2, and 0.5 mM DTT, pH
8.0). The reaction was carried out using a thermomixer at 60 °C for 2
h and stopped by adding ethylenediaminetetraacetic acid (EDTA)
with incubation at 60 °C for 5 min (15 mM EDTA in ﬁnal mixture).
The reaction mixture was then transferred to a black polystyrene half-
volume Corning 96-well plate (Sigma) for the detection procedure.
Detection of DNA Probe through QD−HisDNA-Selective
Hybridization. QD−HisDNA conjugates ([QD] = 2 nM,
[HisDNA] = 30 nM) in nuclease-free duplex buﬀer (30 mM N-(2-
hydroxyethyl)piperazine-N-ethanesulfonic acid, 100 mM potassium
acetate, pH 7.5) were added to the above DSN mixture (ﬁnal
concentration of QDs was 1 nM) and incubated at room temperature
(RT) for 30−60 min. Fluorescence emission was recorded for both
the QD and the dye using a SpectraMax M5 microplate reader
(Molecular Devices).
Speciﬁcity Test. The speciﬁcity of the proposed assay was
evaluated by analyzing samples containing 100 fM, 10 pM, 100 pM, 1
nM, and 20 nM miR-133a, miR-378, miR-423, and miR-148 with one
and three base pair mismatches. AF594-labeled (100 nM) DNA probe
was used under the optimal condition for each assay. The miRNAs
sequences are listed in Table S1.
Preparation of Cell Culture and RNA Isolation. Human cancer
cell lines (MCF-7 and MDA-MB-231) and noncancerous cells
(human embryonic kidney cells HEK 293T) were obtained from
ATCC as described.51 RNA isolation from all cells, cDNA synthesis,
and reverse transcription polymerase chain reaction (RT-PCR) using
commercial kits were conducted according to the manufacturer’s
instructions. A detailed description can be found in our previous
work.51 RNeasy mini spin columns were then used to separate
miRNA-enriched fractions, small RNA species below 200 nt, from the
total RNA aqueous solution, and the extracted miRNA was ﬁnally
obtained by puriﬁcation with an RNeasy mini cleanup kit. The
concentration of miR-21 in the extracted miRNA was determined by
RT-PCR.
Quantiﬁcation of miR-21 in RNA Extracts by RT-PCR and
DSN-Assisted QD-FRET. A commercial kit (miScript SYBR Green
PCR kit) was used for quantiﬁcation of miR-21 by RT-PCR. The
standard curve of PCR was obtained using synthetic miR-21 of known
concentration. A detailed experimental description can be found in
our previous work.51
For miR-21 detection using the DSN-assisted QD-FRET assay, the
RNA extract was added into a mixture of 40 nM Cy3-DNA probe and
0.3 U DSN in the reaction buﬀer (30 μL in total), and the reaction
was stopped by EDTA after 2 h at 60 °C. QD525−HisDNA conjugates
in nuclease-free duplex buﬀer were added to the above DSN mixture
(ﬁnal concentration of QDs was 1 nM) and incubated for 30−60 min
at RT. Fluorescence emission was recorded for both QD525 and Cy3
using a SpectraMax M5 microplate reader (Molecular Devices).
■ RESULTS AND DISCUSSION
Principle of miRNA Detection. A two-step mechanism
for miRNA detection is proposed in Scheme 1: (1) DSN-
mediated dye-labeled DNA probe degradation and (2) QD-
assisted FRET signal generation. In step one, the target
miRNA hybridizes with the dye-labeled DNA probe, forming
heteroduplexes, which are then subjected to a DNA-speciﬁc
Scheme 1. Schematic Representation of miRNA Detection Based on DSN-Assisted Signal Ampliﬁcation and QD-FRET
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cleavage reaction by DSN, leaving the miRNA intact. The
released miRNA can repeatedly and rapidly bind to other DNA
probes in the solution; therefore, one target miRNA strand
leads to cleavage of thousands of DNA probes within 30 min,
under optimal conditions.52 In step two, the remaining
uncleaved DNA probes are hybridized with HisDNA−QDs
to form QD−dye conjugates, generating a signiﬁcant change in
both QD and dye PL intensity (FRET signal). Importantly,
cleaved probes cannot hybridize. The result is a positive
correlation between the concentration of miRNA and the
intensity of QD ﬂuorescence brightness (IQD) or an inverse
relationship between miRNA and the FRET signal (Idye/IQD).
Considering the design criteria presented in the introduc-
tion, our miRNA detection mechanism presents the following
advantages: (1) The two steps of the assay are controlled to
favor either the enzyme or the QD. Step one is performed at
high temperature (60 °C) in a high Mg2+ concentration
(favorable to the DSN), whereas step two is performed at RT
with EDTA added to sequester the Mg2+ (favorable to the
QD). In this way, the performance of the two key components
is tailored to allow optimal performance of the full assay. (2)
No washing or ﬁltration is required between steps 1 and 2. The
temperature is simply decreased from 60 °C to room
temperature, and EDTA is added, which quickly sequesters
Mg2+ and deactivates the DSN. (3) The detection cascade
relies on highly speciﬁc interactions between the target miRNA
and the simple component oligonucleotides and on nonspeciﬁc
detection and cleavage behavior of the DSN. Therefore, the
system should be universal (working with a wide variety of
miRNA sequences) and multiple signaling cascades should
work in parallel. (4) To minimize the separation distance
between donor and acceptor in the FRET system, we used
compact QD−DNA conjugates with minimal surface layer
thickness, synthesized by procedures based on those by
Medintz et al.,49 which have shown their eﬃcacy in various
demanding biological applications.53−55 Furthermore, the dye-
labeled DNA probe was able to bind with the dye oriented
proximal to the QD, bringing the dye as close as possible to the
QD surface.
The proposed system oﬀers some further general advan-
tages. First, the reaction does not require temperature cycling
(as used in polymerase chain reaction (PCR)-based systems),
with incubation at a constant moderate temperature (60
°C) instead, followed by room temperature detection. Second,
target recycling does not suﬀer from nonspeciﬁc priming and
ampliﬁcation that is typical in isothermal ampliﬁcation
techniques using polymerase enzymes to synthesize new
nucleic acids, only a single enzyme and no nucleotides are
required, which simpliﬁes the mechanism compared with
typical isothermal ampliﬁcation techniques. Most importantly,
the carefully designed two-step assay is optimized for both the
enzymatic reaction and the QD-FRET assay. It is important to
Figure 1. Comparative FRET data for the two QD conjugate systems (HisDNA−QD570−AF594 vs BtDNA−QD570−AF594). (A) QD−HisDNA
conjugate. (B) QD−BtDNA. Insets show the corresponding normalized ﬂuorescence emission spectra. (C) FRET ratio comparison between the
two systems. FRET ratio = Idye/IQD. (D) TEM images of zwitterionic ligand (left) and streptavidin (right)-coated QD. The particles were
negatively stained with uranyl acetate. Both were tested in duplex-nuclease-free buﬀer. Scale bar: 50 nm. All error bars in the ﬁgures indicate
standard deviations, N = 3.
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note that there are some challenges associated with using DSN.
For example, it is limited to linear signal ampliﬁcation, it
requires a minimum of 10 bp in hybrid substrates for eﬀective
cleavage, and it requires divalent cations, making it
incompatible with some applications. Nevertheless, its inherent
advantages make it an excellent candidate in many sensing
systems.
Characterization of His6-Modiﬁed DNA Assembly on
QDs and FRET Study. The assembly of DNA on QDs was
achieved by conjugating His6-tag DNA onto zwitterionic-
ligand-protected QDs. To this end, a lipoic acid-derived
zwitterionic ligand was synthesized to modify the QD surface
via phase transfer, which oﬀers good colloidal stability to the
QDs.49 As shown in Figure S1C, the ﬂuorescence and
absorption spectra of the QDs showed only a few nanometer
shift after phase transfer, likely due to surface etching of the
ZnS shell.56 This incomplete surface passivation would
generally result in a decrease in the ﬂuorescence quantum
yield (QY) of QDs. Similar to others, the relative QYs of
CdSxSe1−x/ZnS core/shell QDs after ligand exchange dropped
to ca. half (10−20% in borate buﬀer) of that measured in
hydrophobic solvents (40−50% in toluene). The hydro-
dynamic diameter of ligand-coated QD570 was measured to
be 9 nm by dynamic light scattering, demonstrating the good
dispersibility of the hydrophilic QDs, conﬁrmed by trans-
mission electron microscopy (TEM) (Figure S1D inset). QDs
with such short ligands can be functionalized with
biomolecules through either covalent attachment or metal-
aﬃnity coordination, while retaining high FRET eﬃ-
ciency.49,55,57,58
To take advantage of polyhistidine-driven aﬃnity to the Zn-
rich QD surface, amine-terminated DNA was functionalized
with a hydrazine motif, and then ligated to an aldehyde-
terminated His6 peptide sequence via aniline-catalyzed
hydrazine formation.59,60 Polyhistidine allows rapid binding
(less than 30 min) to QDs via metal-aﬃnity coordination,61,62
which oﬀers rapid high-aﬃnity self-assembly with control over
the number and orientation of moieties assembled per QD.
Importantly, it can be used directly without further
puriﬁcation. Furthermore, the histidine−Zn interaction is less
sensitive to DTT as it does not rely on thiol-binding and thus
constructs are relatively stable in the DTT-rich buﬀer
conditions used herein. Successful self-assembly of QD−
HisDNA conjugates was then checked by agarose gel
electrophoresis and subsequent FRET analysis. As shown in
Figure S2, the shift of the QD−HisDNA conjugate bands
reﬂects the electrophoretic mobility changes resulting from
the increased number of DNA molecules on the QD surface. A
gradual decrease in the migration of QD−HisDNA bands was
observed with the increase of HisDNA/QD ratio, indicating
eﬃcient assembly of HisDNA onto the QDs. Such bands
indicate a low distribution of DNA loading number across the
Figure 2. (A) Twenty percent dPAGE gel electrophoresis analysis of DNA probe and miRNA with DSN. Comparison of dye-labeled DNA probe
hybridized with two types of HisDNA−QD surface: (B) fully complementary HisDNA or (C) HisDNA with two mismatches in the absence (red)
and presence (black) of DSN. Sequence of the dye probe: 5-AF594-ACA AAG TTC TGT AGT GCA CTG A-3, sequence of amine-DNA (FC):
5-GTG CAC TAC AGA ACT TAA A-amine-3, and sequence of amine-DNA (2 M-No1): 5-GTG CAC TAC AGA TAT TAA A-amine-3.
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population, likely following a Poisson distribution. FRET
interactions between the central QD donor and dye acceptors
were examined by hybridizing the complementary acceptor
DNA probe to the QDs.
To verify the beneﬁt of QD−HisDNA bioconjugation,
streptavidin-coated QDs (emission 570 nm) with biotinylated
DNA (BtDNA) were used as a comparison for FRET analysis.
FRET interactions were recorded while increasing the ratio of
AF594-labeled DNA probes self-assembled per QD donor. As
shown in Figure 1, conjugation of the DNA probe to the QD
quenched the donor ﬂuorescence at 570 nm, while at the same
time enhancing the AF594 acceptor ﬂuorescence at 615 nm
through FRET. For the QD−HisDNA conjugate, a signiﬁcant
decrease in QD donor PL was observed with increasing
acceptors, and more than 50% ﬂuorescence was quenched at
ratios ca. 6. In contrast, the QD−BtDNA conjugate needed
more than 12 acceptors to achieve the same quenching eﬀect.
A direct comparison is shown in Figure 1C, plotting FRET
ratios (FRET ratio = Idye/IQD). The increase in FRET ratio is
clearly superior for the HisDNA−QDs, likely as a result of the
thick streptavidin layer on the QD surface. As shown in Figure
1D, the streptavidin layer showed a size of ca. 5 nm by TEM,
which is signiﬁcantly larger than that of the ligand used in the
current system (ca. 2 nm).49 Furthermore, the histidine
peptide places the dye acceptor very close to the QD surface,
resulting in excellent energy transfer and high FRET eﬃciency.
Moreover, as shown in Figure 1A, the FRET between
QD570 (donor) and AF594-DNA (acceptor) reaches a max-
imum when the dye/QD ratio reached ca. 15. Further addition
of AF594 does not signiﬁcantly decrease the PL of QD570. We
therefore determined that the optimal ratio of HisDNA on the
QD surface for best FRET performance in our system is ca. 15.
DSN Catalytic Activity on DNA−miRNA Duplexes. We
performed an initial test of the DSN-mediated target-recycling
system using a fully complementary (FC) DNA−miRNA
heteroduplex and DSN, under optimal reaction conditions,
with the products analyzed by 20% denatured polyacrylamide
gel electrophoresis (dPAGE). As shown in Figure 2A, DSN
showed strong cleavage preference only toward DNA strands
in DNA−miRNA duplexes, as previously reported.46,63
However, we observed that although the 22-base DNA strands
were cleaved into smaller fragments, some of them still
retained the ability to hybridize to a full-complementary (FC)
HisDNA to quench QD (Figure 2B) at room temperature.
This would result in a false negative result. The basis of the
proposed strategy is the diﬀerential hybridization ability of
short oligonucleotide fragments after DSN cleavage versus
intact DNA probes (22 bases) to the HisDNA−QD, according
to the nature of the Watson−Crick base pairing. To avoid
these false negatives from the cleaved DNA fragments, two
base pair mismatches (2 M) were introduced to the HisDNA
sequence at the amine-functionalized end. The mismatches will
be present close to the QD surface. Therefore, while this
maintained a suﬃcient hybridization eﬃciency between the
HisDNA and intact DNA probe, the FRET signal caused by
the cleaved fragments can be completely impaired (Figure 2C)
owing to the low Tm between the cleaved fragments and the
HisDNA with mismatches. It is very important to choose the
appropriate position for mismatches within the HisDNA
sequence because the use of a mismatched sequence will also
aﬀect the FRET eﬃciency between intact DNA probe and
HisDNA, as shown in Figure S3, due to the Tm diﬀerences.
Indeed, the discrimination ratio (the ratio of quenching
eﬃciencies from the intact DNA versus the cleaved DNA
fragment) from 2 M-HisDNA is negligible compared to that of
the FC-HisDNA.
Optimization of the DSN Reaction. To maximize DSN
performance, the reaction parameters including the temper-
ature and the concentration of MgCl2, DTT, and DSN were
optimized. To readily measure the cleavage eﬃciency of DSN,
we used a dual-labeled DNA probe with AF594 at one end and a
BHQ3 quencher at the other end. The cleavage of DNA by
DSN removed ﬂuorescent AF594 DNA fragments from the
quencher fragments, resulting in a signiﬁcant enhancement in
the ﬂuorescence signal. The rate of change in ﬂuorescence
intensity was therefore proportional to the activity of DSN.
The highest signal was noted in the buﬀer containing 15 mM
MgCl2 and 0.5 mM DTT at 60 °C (Figure S4), which is 10.6
°C lower than the estimated Tm of the miR-148−DNA duplex
(Figure S5). Although a higher temperature facilitated faster
Figure 3. Eﬀect of DSN dose on assay performance. (A) Dual-labeled system in the DSN cleavage step showed that normalized ﬂuorescence
intensity (F and F0 are the AF594 ﬂuorescent intensities in the presence and absence of the target) increases rapidly when the dosage of DSN
increased from 0 to 0.8 U within the same time. (B) DSN in the reaction mixture aﬀects the next QD-FRET step: with the same concentration of
target miRNA, more DSN resulted in higher QD ﬂuorescence, which indicated less FRET occurring in the system. [AF594-DNA] = 40 nM, [QD570]
= 1 nM, [HisDNA] = 15 nM. All error bars in the ﬁgures indicate standard deviations, N = 3.
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dissociation of miRNA, it also caused denaturation of the
DNA−RNA heteroduplexes, resulting in a dramatic decrease in
the peak value. Other key factors are incubation time for the
assay and the absolute amount of DSN used. We set out to
investigate these by monitoring the change in the ﬂuorescence
signal upon addition of varying amounts of DSN enzyme
versus time. As shown in Figure S6, with a ﬁxed DSN amount,
if the incubation time is suﬃciently long, this cyclic reaction
will repeat until all the probes are consumed (Figure S6A).
DSN is an extremely thermostable enzyme, and it has been
reported that 7% of its activity can be retained even after
incubating at 100 °C for 30 min.46 Other DSN-based assays
have reported their reaction time from 30 to 120 min under
various buﬀer conditions and temperatures.29,51,52,64−70
Although a longer reaction time could achieve a higher
sensitivity, 2 h was chosen to balance the total assay time. For
the amount of DSN used in the assay, the kinetics study in
Figure S6B showed that ﬂuorescence of AF594 increased rapidly
with the increased DSN dose from 0 to 0.8 U. Importantly, the
nonspeciﬁc background caused by DSN digesting ssDNA
probes is negligible. As shown in Figure 3A, the relative signal
change (F − F0/F0, where F0 and F are the ﬂuorescent
intensities in the absence and presence of a target) kept
increasing with increasing DSN. This is because the DSN
enzyme has no preference toward ssDNA due to its strict
cleavage speciﬁcity. This agreed with the result from dPAGE
gel analysis (Figure 2A).
A further reﬁnement of the assay was required to restrict the
eﬀect that DSN could have during the detection step when the
QD−HisDNA conjugates were added. Although the addition
of EDTA after the ampliﬁcation reaction (which sequesters
Mg2+ ions that are required for DSN to function) quenched
the DSN reaction, we found that the DSN could still aﬀect the
subsequent QD-FRET detection step, as shown in Figure 3B.
After DSN cleavage, we added QD−HisDNA conjugates for
hybridization of the uncleaved DNA probe. With the same
concentration of target miRNA, more DSN resulted in a
relatively higher QD ﬂuorescence, which indicated less FRET
occurring in the system. This resulted in an impaired dynamic
range without signiﬁcant improvement in the assay sensitivity.
When a large amount of enzyme was used, it was active on the
HisDNA−DNA duplexes on the QD surface, cleaving the
duplexes and releasing the dye from QD. Therefore we set out
to investigate the eﬀect of the amount of DSN on the ﬁnal QD-
FRET ratio, as shown in Figure S7. Here, the DNA probe was
incubated with varied DSN amounts without target and then
QD−HisDNA conjugates were added after deactivation of
DSN by sequestering Mg2+ using EDTA. As can be seen from
Figure S7, the FRET ratio kept decreasing with the increasing
DSN concentration, in agreement with Figure 3B. Although a
greater DSN concentration would greatly speed up the
cleavage reaction, it would diminish the subsequent QD-
FRET eﬃciency, thus aﬀecting the assay sensitivity. To achieve
a high sensitivity within a reasonable time frame, we chose 0.3
U DSN in our experiment.
Optimization of the Dye-Labeled DNA Probe. As can
be seen from Scheme 1, the initial dye-labeled DNA probe
concentration was signiﬁcantly important for the assay
sensitivity. To achieve the best assay performance, the
concentration of DNA probe should be kept high enough to
ensure that the cleavage of DNA only results from the target
miRNA hybridization process, as well as to achieve a wide
dynamic range for the assay. On the other hand, a low
concentration of DNA probe in the system should yield a
distinguishable FRET signal at low miRNA concentrations. As
noted from Figure 1A, above the linear dose−response zone,
the FRET ratio slowly levels oﬀ. Therefore, DNA probe-
induced FRET of QD−HisDNA without the DSN ampliﬁca-
tion was investigated under the same buﬀer conditions. Most
importantly, QD−HisDNA conjugates were found unstable
and quenched in the pure DSN optimal buﬀer (data not
shown); however, the design of a two-step assay, using EDTA
to sequester all of the free Mg2+ ions before adding the QDs,
greatly improved their stability and ﬂuorescence. Figure S8
shows the FRET ratio of a mixed solution containing QD−
HisDNA in nuclease-free duplex buﬀer with varying amounts
Figure 4. Sensitive and selective detection of miR-148 in pure buﬀer. (A) Target dose−response normalized (FRET0 − FRET), where FRET0 and
FRET are the FRET ratio in the absence and presence of a target, FRET ratio = Idye/IQD, where the QD channel at λ = 570 nm and dye channel at λ
= 615 nm, [AF594-DNA] = 40 nM, [DSN] = 0.3 U, [QD570] = 1 nM, and [HisDNA] = 15 nM. The DSN reaction was performed at 60 °C for 2 h
and QD−HisDNA, selective hybridization was carried out at RT for 40 min. All error bars in the ﬁgures indicate standard deviations; N = 6. (B)
Target miRNA-speciﬁc test. DNA probe (100 nM) was incubated with 20 and 1 nM target for 2 h. Normalized ﬂuorescence intensities with various
miRNAs with 0.1 U DSN, where F0 and F are the ﬂuorescence signals without and with the miRNA target, respectively. All error bars in the ﬁgures
indicate standard deviations; N = 3.
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of DNA probe in the DSN reaction buﬀer. Importantly, the
same ﬁnal EDTA concentration was used. With an increasing
amount of DNA probe, the FRET ratio increased due to QD−
dye FRET. However, the FRET ratio in this mixture buﬀer
condition was much lower than the one tested in the ideal
buﬀer in Figure 1C. This was due to interference and
impairment by the enzyme buﬀer. The FRET ratio in Figure
S8 changed in response to diﬀerent concentrations of DNA
probe. We found a 40 nM concentration of the initial dye-
labeled DNA probe to be enough to maintain a compromise
between the dynamic range and the sensitivity of our assay and
therefore chose this for the following detection of miRNA.
Detection Performance of the Full Assay. Next, we
combined the two assay steps, the DSN ampliﬁcation and QD-
FRET detection, for sensing miRNA-148. We chose a QD570
and AF594 FRET pair for the miR-148 detection assay. The
optimized conditions were as follows: in step 1, 40 nM DNA
probe, 0.3 U DSN, 50 mM Tris−HCl, 15 mM MgCl2, and 0.5
mM DTT, at pH 8.0 and 60 °C, for 2 h; then, in step 2, 1 nM
QD−HisDNA conjugates. In the full assay, we observed a
positive dose−response in the range of 10−15−10−8 M miRNA,
shown in Figure 4A. The limit of detection (LOD) was 42 fM
(or 1.2 amol of miRNA) based on 3σ. The saturation point
was above 10 nM, indicating a relatively large dynamic range.
We obtained a 3 order of magnitude improvement in the assay
sensitivity through DSN-mediated miRNA recycling compared
to that of the nonampliﬁed QD-FRET-based assay (LOD = 72
pM), as shown in Figure S9. This is consistent with previous
ﬁndings.51,52,71 The capability of this assay to distinguish the
target miRNA from other miRNA family members was
highlighted by the ability of mismatch discrimination, as
shown in Figure 4B. Indeed, we observed a signiﬁcant
ﬂuorescence response only in the presence of miR-148,
whereas the addition of the other miRNA gave negligible
changes. Interestingly, only a slight decrease in the signal was
observed from miR-148 with 1 nt mismatch, indicating that
DSN still showed cleavage activity on DNA in corresponding
duplexes when there was a considerable amount of target
existing in the system. Similar results have been reported
before.51 Furthermore, the speciﬁcity can be improved by
decreasing the target concentration, as shown in Figure S10.
These results indicate that DSN exhibits good selectivity for
discriminating among the miRNA family members.
Detection of Endogenous miRNA from Human Cells.
To demonstrate the capability to quantify miRNA in a
biological sample, we used the DSN-QD method to analyze
the endogenous mature miR-21 in diﬀerent cell lines. The
miRNA extracted from human breast cancer cells (MCF-7 and
MDA-MB-231) and noncancerous human embryonic kidney
cells HEK 293T was diluted and directly used. A standard
curve (Figure S11B) was made for quantifying the expression
levels of miR-21. Figure S12 shows the absolute concentration
of miR-21 measured by the QD-DSN method in comparison
with RT-PCR as the reference. The expression levels of miR-21
in MCF-7 and MDA-MB-231 cells determined by both
methods were higher than those in HEK 293T cells, indicating
that miR-21 is highly upregulated in cancer cells as compared
to that in normal cells. To evaluate the performance of our
method in terms of sensitivity and speciﬁcity, we further
constructed a contingency table (Table S2), in which the PCR
data set was used as the reference and the upper 95%
conﬁdence interval concentration in HEK 293T given by PCR
was used as the criterion of positivity. On the basis of this
analysis, the sensitivity and speciﬁcity of our assay are 100 and
50%, respectively. The obtained results demonstrate that
88.2% of the tested biological samples using the QD-DSN
method were accurately discriminated compared with the RT-
PCR detection. Considering the simplicity and homogeneous
nature (no washing or separation steps) of our assay, it has
promise for application in research or clinical settings,
especially with further optimization of the QD surface
chemistry, which we feel is currently a limiting factor.
■ CONCLUSIONS
In this work, we set out to assess the utility of coemploying
enzyme-mediated target recycling and ﬂuorescent QDs for
miRNA detection. We have constructed a simple, sensitive, and
speciﬁc miRNA detection mechanism based on DSN-mediated
target recycling and compact QD−DNA constructs generating
FRET signals. The DSN-mediated ampliﬁcation oﬀers unique
advantages of high ampliﬁcation eﬃciency, isothermal nature,
and no nonspeciﬁc priming. We demonstrated a detection limit
of 42 fM for miR-148 with outstanding selectivity versus
mismatched sequences and other miRNAs. In addition, the
proposed method was successfully employed for detection of
miR-21 using an alternative FRET pair, which was compared
with qRT-PCR for the quantitative analysis of miR-21 in
biological samples that are rarely interrogated using QD-FRET
assays due to the challenging nature of their complex
composition. This highly sensitive and speciﬁc method
therefore shows potential for further development toward a
versatile miRNA detection assay. We envisage that further
improvements could be made to the detection mechanism with
advancements in ultrathin surface chemistries to reduce
nonspeciﬁc binding while maintaining the ﬂuorescence bright-
ness of QDs.
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(44) Molnaŕ, M.; Ning, Z.-J.; Chen, Y.; Friberg, P.; Gan, L.-M.; Fu,
Y. Effects of K+ and Na+ Ions On The Fluorescence of Colloidal
CdSe/CdS and CdSe/ZnS Quantum Dots. Sens. Actuators, B 2011,
155, 823−830.
(45) Li, L.; Chen, Y.; Tian, G.; Akpe, V.; Xu, H.; Gan, L.-M.; Skrtic,
S.; Luo, Y.; Brismar, H.; Fu, Y. Reversible Modification of CdSe−
CdS/ZnS Quantum Dot Fluorescence by Surrounding Ca2+ Ions. J.
Phys. Chem. C 2014, 118, 10424−10433.
(46) Anisimova, V. E.; Rebrikov, D. V.; Shagin, D. A.; Kozhemyako,
V. B.; Menzorova, N. I.; Staroverov, D. B.; Ziganshin, R.; Vagner, L.
L.; Rasskazov, V. A.; Lukyanov, S. A.; Shcheglov, A. S. Isolation,
Characterization and Molecular Cloning of Duplex-Specific Nuclease
From The Hepatopancreas of The Kamchatka Crab. BMC Biochem.
2008, 9, 14.
(47) Song, H.; Wang, Q.; Guo, Y.; Liu, S.; Song, R.; Gao, X.; Dai, L.;
Li, B.; Zhang, D.; Cheng, J. Microarray Analysis of MicroRNA
Expression In Peripheral Blood Mononuclear Cells of Critically Ill
Patients with Influenza A (H1N1). BMC Infect. Dis. 2013, 13, 257.
(48) Kumarswamy, R.; Volkmann, I.; Thum, T. Regulation and
function of miRNA-21 in health and disease. RNA Biol. 2011, 8, 706−
713.
(49) Susumu, K.; Oh, E.; Delehanty, J. B.; Blanco-Canosa, J. B.;
Johnson, B. J.; Jain, V.; Hervey, W. J.; Algar, W. R.; Boeneman, K.;
Dawson, P. E.; Medintz, I. L. Multifunctional Compact Zwitterionic
Ligands for Preparing Robust Biocompatible Semiconductor
Quantum Dots and Gold Nanoparticles. J. Am. Chem. Soc. 2011,
133, 9480−9496.
(50) Prasuhn, D. E.; Blanco-Canosa, J. B.; Vora, G. J.; Delehanty, J.
B.; Susumu, K.; Mei, B. C.; Dawson, P. E.; Medintz, I. L. Combining
Chemoselective Ligation with Polyhistidine-Driven Self-Assembly for
the Modular Display of Biomolecules on Quantum Dots. ACS Nano
2010, 4, 267−278.
(51) Kim, E.; Howes, P. D.; Crowder, S. W.; Stevens, M. M. Multi-
Amplified Sensing of MicroRNA by a Small DNA Fragment-Driven
Enzymatic Cascade Reaction. ACS Sens. 2017, 2, 111−118.
(52) Yin, B.-C.; Liu, Y.-Q.; Ye, B.-C. One-Step, Multiplexed
Fluorescence Detection of microRNAs Based on Duplex-Specific
Nuclease Signal Amplification. J. Am. Chem. Soc. 2012, 134, 5064−
5067.
(53) Hess, K. L.; Oh, E.; Tostanoski, L. H.; Andorko, J. I.; Susumu,
K.; Deschamps, J. R.; Medintz, I. L.; Jewell, C. M. Engineering
Immunological Tolerance Using Quantum Dots to Tune the Density
of Self-Antigen Display. Adv. Funct. Mater. 2017, 27, No. 1700290.
(54) Vranish, J. N.; Ancona, M. G.; Oh, E.; Susumu, K.; Medintz, I.
L. Enhancing Coupled Enzymatic Activity By Conjugating One
Enzyme to A Nanoparticle. Nanoscale 2017, 9, 5172−5187.
(55) Agarwal, R.; Domowicz, M. S.; Schwartz, N. B.; Henry, J.;
Medintz, I.; Delehanty, J. B.; Stewart, M. H.; Susumu, K.; Huston, A.
L.; Deschamps, J. R.; Dawson, P. E.; Palomo, V.; Dawson, G. Delivery
and Tracking of Quantum Dot Peptide Bioconjugates in an Intact
Developing Avian Brain. ACS Chem. Neurosci. 2015, 6, 494−504.
(56) Liu, D.; Snee, P. T. Water-Soluble Semiconductor Nanocrystals
Cap Exchanged with Metalated Ligands. ACS Nano 2011, 5, 546−
550.
(57) Aldeek, F.; Safi, M.; Zhan, N. Q.; Palui, G.; Mattoussi, H.
Understanding the Self-Assembly of Proteins onto Gold Nano-
particles and Quantum Dots Driven by Metal-Histidine Coordination.
ACS Nano 2013, 7, 10197−10210.
(58) Breger, J. C.; Ancona, M. G.; Walper, S. A.; Oh, E.; Susumu, K.;
Stewart, M. H.; Deschamps, J. R.; Medintz, I. L. Understanding How
Nanoparticle Attachment Enhances Phosphotriesterase Kinetic
Efficiency. ACS Nano 2015, 9, 8491−8503.
(59) Dirksen, A.; Dawson, P. E. Rapid Oxime and Hydrazone
Ligations with Aromatic Aldehydes for Biomolecular Labeling.
Bioconjugate Chem. 2008, 19, 2543−2548.
(60) Spicer, C. D.; Davis, B. G. Selective chemical protein
modification. Nat. Commun. 2014, 5, No. 4740.
(61) Pons, T.; Medintz, I. L.; Wang, X.; English, D. S.; Mattoussi, H.
Solution-Phase Single Quantum Dot Fluorescence Resonance Energy
Transfer. J. Am. Chem. Soc. 2006, 128, 15324−15331.
(62) Boeneman, K.; Deschamps, J. R.; Buckhout-White, S.; Prasuhn,
D. E.; Blanco-Canosa, J. B.; Dawson, P. E.; Stewart, M. H.; Susumu,
K.; Goldman, E. R.; Ancona, M.; Medintz, I. L. Quantum Dot DNA
Bioconjugates: Attachment Chemistry Strongly Influences the
Resulting Composite Architecture. ACS Nano 2010, 4, 7253−7266.
ACS Applied Materials & Interfaces Research Article
DOI: 10.1021/acsami.8b07250
ACS Appl. Mater. Interfaces 2018, 10, 28290−28300
28299
(63) Shagin, D. A.; Rebrikov, D. V.; Kozhemyako, V. B.; Altshuler, I.
M.; Shcheglov, A. S.; Zhulidov, P. A.; Bogdanova, E. A.; Staroverov,
D. B.; Rasskazov, V. A.; Lukyanov, S. A Novel Method for SNP
Detection Using a New Duplex-Specific Nuclease From Crab
Hepatopancreas. Genome Res. 2002, 12, 1935−1942.
(64) Shen, W.; Deng, H.; Ren, Y.; Gao, Z. A Real-Time Colorimetric
Assay For Label-Free Detection of MicroRNAs Down to Sub-
Femtomolar Levels. Chem. Commun. 2013, 49, 4959−4961.
(65) Wang, S.; Fu, B.; Wang, J.; Long, Y.; Zhang, X.; Peng, S.; Guo,
P.; Tian, T.; Zhou, X. Novel Amplex Red Oxidases Based on
Noncanonical DNA Structures: Property Studies and Applications in
MicroRNA Detection. Anal. Chem. 2014, 86, 2925−2930.
(66) Yan, L.; Yan, Y.; Pei, L.; Wei, W.; Zhao, J. A G-quadruplex
DNA-based, Label-Free and Ultrasensitive Strategy for microRNA
Detection. Sci. Rep. 2014, 4, No. 7400.
(67) Hao, N.; Dai, P.-P.; Yu, T.; Xu, J.-J.; Chen, H.-Y. A Dual
Target-Recycling Amplification Strategy for Sensitive Detection of
MicroRNAs Based on Duplex-Specific Nuclease and Catalytic Hairpin
Assembly. Chem. Commun. 2015, 51, 13504−13507.
(68) Shen, W.; Yeo, K. H.; Gao, Z. A Simple and Highly Sensitive
Fluorescence Assay for MicroRNAs. Analyst 2015, 140, 1932−1938.
(69) Li, Y.; Zhang, J.; Zhao, J.; Zhao, L.; Cheng, Y.; Li, Z. A Simple
Molecular Beacon With Duplex-Specific Nuclease Amplification For
Detection of MicroRNA. Analyst 2016, 141, 1071−1076.
(70) Lv, W.; Zhao, J.; Situ, B.; Li, B.; Ma, W.; Liu, J.; Wu, Z.; Wang,
W.; Yan, X.; Zheng, L. A Target-Triggered Dual Amplification
Strategy for Sensitive Detection of MicroRNA. Biosens. Bioelectron.
2016, 83, 250−255.
(71) Degliangeli, F.; Kshirsagar, P.; Brunetti, V.; Pompa, P. P.;
Fiammengo, R. Absolute and Direct MicroRNA Quantification Using
DNA−Gold Nanoparticle Probes. J. Am. Chem. Soc. 2014, 136, 2264−
2267.
ACS Applied Materials & Interfaces Research Article
DOI: 10.1021/acsami.8b07250
ACS Appl. Mater. Interfaces 2018, 10, 28290−28300
28300
